KRAS and neoplasm: Here, we found that both in human samples and mouse models of CRC, ZEB1 has a tumor-promoting role and determines poorer prognosis in mutant KRAS CRC but, surprisingly, it functions as a tumor suppressor and determines better prognosis in BRAF CRC (see schematic summary in Figure 8).